It has been demonstrated experimentally that PHF6 loss can enhance the oncogenic activity of NOTCH1 mutations; therefore, PHF6 and NOTCH1 co-mutation are more tightly linked to T-ALL pathogenesis and leukemia-associated mortality (48, 49). Here, PHF6 is linked to leukemia.